Kite Pharma
biomedical engineering company that develops cancer immunotherapy products
Press Enter · cited answer in seconds
0 sources
Financials
Self-reported XBRL data from 3 annual filings
Revenue
$22.17M
Net Income
-$267.07M
Assets
$524.30M
■ Revenue ■ Net Income
Source: SEC EDGAR · latest 10-K filed 2016-12-31 · accession
0001510580-17-000003Kite Pharma
Summary
Kite Pharma is a business[1]. It ranks in the top 4% of business entities by monthly Wikipedia readership (385 views/month).[2]
Key Facts
- Kite Pharma is in the country of United States[3].
- Kite Pharma's instance of is recorded as business[4].
- Kite Pharma's instance of is recorded as public company[5].
- Kite Pharma's founder is recorded as Arie Belldegrun[6].
- Kite Pharma's headquarters location is recorded as Santa Monica[7].
- Kite Pharma's stock exchange is recorded as Nasdaq[8].
- Kite Pharma's industry is recorded as biomedical engineering[9].
- 2009 marks the founding of Kite Pharma[10].
- Kite Pharma's parent organization or unit is recorded as Gilead Sciences[11].
- Kite Pharma's official website is recorded as http://www.kitepharma.com/[12].
- Kite Pharma's product or material produced is recorded as cancer immunotherapy[13].
- Kite Pharma's social media followers is recorded as {'amount': '+3826'}[14].
Body
Founding
Kite Pharma's founder is recorded as Arie Belldegrun[6]. 2009 marks the founding of it[10].
Operations
Kite Pharma's headquarters location is recorded as Santa Monica[7]. Its parent organization or unit is recorded as Gilead Sciences[11].
Industry
Kite Pharma's industry is recorded as biomedical engineering[9].
Ownership
Kite Pharma's stock exchange is recorded as Nasdaq[8]. Its product or material produced is recorded as cancer immunotherapy[13].
Why It Matters
Kite Pharma ranks in the top 4% of business entities by monthly Wikipedia readership (385 views/month).[2]